EP2870261
BIOMARKERS ASSOCIATED WITH CDK INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.6.2013EP published:
6.12.2017EP application number:
13735529.3
EPO information:
European Patent Register
Max expiry date:
25.6.2033
Title:
BIOMARKERS ASSOCIATED WITH CDK INHIBITORS
Timeline
Today
26.6.2013EP application
6.12.2017EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02215-5450, Boston, MA, US
Name:
Broad InstituteAddress:
44 Binney Street, 02115, Boston, Massachusetts, US
Inventor
Name:
CAPONIGRO, GiordanoAddress:
Cambridge, MA, US
Name:
DELACH, ScottAddress:
Cambridge, MA, US
Name:
GARRAWAY, LeviAddress:
Boston, MA, US
Name:
JAGANI, ZainabAddress:
Cambridge, MA, US
Name:
KIM, SunkyuAddress:
Cambridge, MA, US
Name:
KRYUKOV, GregoryAddress:
Cambridge, MA, US
Priority
Number:
201261669534 PDate:
9.7.2012Country:
US
Classification
Categories:
C12Q 1/68